RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
https://doi.org/10.14412/1995-4484-2016-105-107
Abstract
The paper describes a clinical case of recurrent microscopic polyangiitis diagnosed 10 years after kidney allotransplantation that was accompanied by the hyperproduction of antibodies to myeloperoxidase, graft damage with the morphological picture of pauci-immune extracapillary glomerulonephritis with crescents and other systemic manifestations, including interstitial lung injury complicated by hemoptysis. An effect is produced by biological anti-B-cell therapy with rituximab. The discussion involves the detailed review of the literature.
About the Authors
N. F. Frolova
City Polyclinic FiftyTwo, Moscow Healthcare Department
Russian Federation
7, Medynskaya St., Build. 1, Moscow 117546
Russian Federation
7, Medynskaya St., Build. 1, Moscow 117546
L. Yu. Artyukhina
City Polyclinic FiftyTwo, Moscow Healthcare Department
Russian Federation
7, Medynskaya St., Build. 1, Moscow 117546
Russian Federation
7, Medynskaya St., Build. 1, Moscow 117546
E. S. Stolyarevich
City Polyclinic FiftyTwo, Moscow Healthcare Department;
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Ministry of Health of Russia
Russian Federation
Russian Federation
7, Medynskaya St., Build. 1, Moscow 117546;
1, Shchukinskaya St., Moscow 123182
References
1. Berden A, Ferrario F, Hagen E, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628-36. doi: 10.1681/ASN.2010050477
2. Ferrario F, Vanzati A, Pagni F. Pathology of ANCA-associated vasculitis. Clin Exp Nephrol. 2013;17(5):652-8. doi: 10.1007/s10157-012-0701-8
3. Guillevin L, Pagnoux C, Seror R, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine. 2011;90:19-27. doi: 10.1097/MD.0b013e318205a4c6
4. Бекетова ТВ. Микроскопический полиангиит, ассоциированный с антинейтрофильными цитоплазматическими антителами: особенности клинического течения. Терапевтический архив. 2015;87(5):33-47 [Beketova TV. Microscopic polyangiitis associated with anti-neutrophil cytoplasmic antibody: clinical features. Terapevticheskii arkhiv. 2015;87(5):33-47 (In Russ.)].
5. Pagnoux C, Hogan S, Chin H, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts. Arthritis Rheum. 2008;58:2908-18. doi: 10.1002/art.23800
6. Ntatsaki E, Carruthers D, Chakravarty K, et al. BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53(12):2306-9. doi: 10.1093/rheumatology/ket445
7. Moran S, Little M. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol. 2014;26(1):37-41. doi: 10.1097/BOR.0000000000000006
8. Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant. 2003;18(5):1001-4. doi: 10.1093/ndt/gfg087
9. Столяревич ЕС, Томилина НА. Эволюция представлений о причинах поздней дисфункции трансплантированной почки. Вестник трансплантологии и искусственных органов. 2015;17(2):113-5 [Stolyarevich ES, Tomilina NA. The evolution of ideas about the causes of late dysfunction of the transplanted kidney. Vestnik transplantologii i iskusstvennykh organov. 2015;17(2):113-5 (In Russ.)].
10. Stegeman C, Tervaert J, van Son W, Tegzess A. Necrotizing glomerulonephritis associated with antimyeloperoxidase antibodies in a renal transplant recipient with renal failure of unknown origin. Nephrol Dial Transplant. 1994;9(7):839-42.
11. Kuross S, Davin T, Kjellstrand CM. Wegener's granulomatosis with severe renal failure: clinical course and results of dialysis and transplantation. Clin Nephrol. 1981;16(4):172-80.
12. Clarke A, Bitton A, Eappen R, et al. Treatment of Wegener's granulomatosis after renal transplantation: is cyclosporine the preferred treatment? Transplantation. 1990;50(6):1047-51. doi: 10.1097/00007890-199012000-00030
13. Nachman P, Segelmark M, Westman K, et al. Recurrent ANCAassociated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int. 1999;56(4):1544-50. doi: 10.1046/j.1523-1755.1999.00666.x
14. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol. 1998;9(7):1258-63.
15. Gera M, Griffin M, Specks U, et al. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int. 2007;71(12):1296-301. doi: 10.1038/sj.ki.5002244
16. Geetha D, Seo P. Renal transplantation in the ANCA-associated vasculitides. Am J Transplant. 2007;7(12):2657-62. doi: 10.1111/j.1600-6143.2007.01988.x
17. Murakami C, Manoharan P, Carter-Monroe N, Geetha D. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant. Transpl Int. 2013;26(12):1225-31. doi: 10.1111/tri.12203
Review
For citations:
Frolova N.F., Artyukhina L.Yu., Stolyarevich E.S. RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION. Rheumatology Science and Practice. 2016;54(1):105-107. (In Russ.) https://doi.org/10.14412/1995-4484-2016-105-107
Views:
795
Email this article 